Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trump’s Election Could Bring ‘Best Of Times’ For Pharma

Executive Summary

Obama administration wasn’t bad but had ‘less than thrilling moments,’ BIO exec says; former FDA Commissioner says leadership, not scientific, skill is key attribute for next agency chief.

You may also be interested in...



Trump Win Is False Security For Drug Makers, Allergan CEO Warns

Industry should act on drug pricing now while there is a post-election reprieve, Allergan CEO Brent Saunders said during the Forbes Healthcare Summit. Trump is a populist who will jump on the next big pricing scandal, he said.

Who To Watch In Health Care Policy Under Trump

From Newt Gingrich to President Barack Obama, speculation about who will be the central figures to watch in US health care policy in the Trump administration occupied panelists at the Partnering for Cures meeting.

Trump’s FDA Reform Agenda: Patient-Focused Approvals

A posting on the transition website takes a much milder tone than the GOP platform issued over the summer.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS119523

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel